TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/4/23 21:41 | 10/2/23 | FRTX | Fresh Tracks Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Sklawer Andrew D | CO | O | P,CEO | M.d | 0 | 0.00 | 0 | 55 | 39 | D | |||||||||||||||
5/19/21 17:03 | 5/17/21 | BBI | Brickell Biotech, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Sklawer Andrew D | CO | O | COO,Secr | P | 12 | 0.8000 | 0 | 15 | 14 | 125 | D | ||||||||||||||
3/17/21 16:53 | 3/16/21 | BBI | Brickell Biotech, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Sklawer Andrew D | CO | O | COO,Secr | M.d | 0 | 0.00 | 0 | 20 | 22 | 109 | D | ||||||||||||||
6/22/20 19:53 | 6/22/20 | BBI | Brickell Biotech, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Sklawer Andrew D | CO | O | COO,Secr | P.d | 0 | 0.00 | 0 | 13 | 16 | 96 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |